The University of Chicago Header Logo

Connection

Sangeeta Bhorade to Lung Transplantation

Back to Details
This is a "connection" page, showing publications Sangeeta Bhorade has written about Lung Transplantation.
Sangeeta Bhorade
Connection Strength
8.922
Lung Transplantation
  1. Frailty and aging-associated syndromes in lung transplant candidates and recipients. Am J Transplant. 2021 06; 21(6):2018-2024.
    View in: PubMed
    Score: 0.552
  2. Lung transplantation in scleroderma: recent advances and lessons. Curr Opin Rheumatol. 2018 11; 30(6):562-569.
    View in: PubMed
    Score: 0.476
  3. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation. PLoS One. 2014; 9(7):e103643.
    View in: PubMed
    Score: 0.354
  4. The lung microbiome after lung transplantation. Expert Rev Respir Med. 2014 Apr; 8(2):221-31.
    View in: PubMed
    Score: 0.346
  5. Invited commentary. Ann Thorac Surg. 2014 Jan; 97(1):274-5.
    View in: PubMed
    Score: 0.340
  6. Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013 Jun; 143(6):1717-1724.
    View in: PubMed
    Score: 0.327
  7. Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation. J Heart Lung Transplant. 2013 Jul; 32(7):701-6.
    View in: PubMed
    Score: 0.325
  8. A longitudinal study of patients' symptoms before and during the first year after lung transplantation. Clin Transplant. 2012 Nov-Dec; 26(6):E576-89.
    View in: PubMed
    Score: 0.311
  9. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. J Heart Lung Transplant. 2011 Feb; 30(2):175-81.
    View in: PubMed
    Score: 0.272
  10. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation. 2010 Sep 15; 90(5):540-6.
    View in: PubMed
    Score: 0.271
  11. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med. 2011 Feb 01; 183(3):379-87.
    View in: PubMed
    Score: 0.270
  12. Current trends in immunosuppression for lung transplantation. Semin Respir Crit Care Med. 2010 Apr; 31(2):172-8.
    View in: PubMed
    Score: 0.262
  13. Immunosuppression for lung transplantation. Proc Am Thorac Soc. 2009 Jan 15; 6(1):47-53.
    View in: PubMed
    Score: 0.241
  14. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant. 2008 Sep; 27(9):990-4.
    View in: PubMed
    Score: 0.235
  15. Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection. Chest. 2007 Feb; 131(2):533-8.
    View in: PubMed
    Score: 0.211
  16. Evolving immunosuppressive regimens for lung transplant recipients. Semin Respir Crit Care Med. 2006 Oct; 27(5):470-9.
    View in: PubMed
    Score: 0.206
  17. Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest. 2006 Sep; 130(3):847-54.
    View in: PubMed
    Score: 0.205
  18. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. J Heart Lung Transplant. 2005 Apr; 24(4):421-5.
    View in: PubMed
    Score: 0.185
  19. Lung transplantation for interstitial lung disease. Clin Chest Med. 2004 Dec; 25(4):773-82, vii-viii.
    View in: PubMed
    Score: 0.181
  20. Immunosuppressive regimens in lung transplant recipients. Drugs Today (Barc). 2004 Dec; 40(12):1003-12.
    View in: PubMed
    Score: 0.181
  21. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant. 2003 Dec; 3(12):1570-5.
    View in: PubMed
    Score: 0.169
  22. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant. 2002 Dec; 21(12):1274-82.
    View in: PubMed
    Score: 0.158
  23. Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients. J Heart Lung Transplant. 2001 Sep; 20(9):928-34.
    View in: PubMed
    Score: 0.145
  24. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. J Heart Lung Transplant. 2021 11; 40(11):1251-1266.
    View in: PubMed
    Score: 0.144
  25. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000 Dec; 19(12):1199-204.
    View in: PubMed
    Score: 0.137
  26. Clinical relevance of lung-restricted antibodies in lung transplantation. Hum Immunol. 2019 Aug; 80(8):595-601.
    View in: PubMed
    Score: 0.123
  27. Lung transplantation at Loyola University Medical Center. Clin Transpl. 1999; 281-8.
    View in: PubMed
    Score: 0.120
  28. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2018 01 15; 197(2):235-243.
    View in: PubMed
    Score: 0.113
  29. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Oct; 14(10):1514-1522.
    View in: PubMed
    Score: 0.110
  30. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. J Heart Lung Transplant. 2016 Apr; 35(4):500-507.
    View in: PubMed
    Score: 0.098
  31. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. Am J Transplant. 2016 Mar; 16(3):833-40.
    View in: PubMed
    Score: 0.097
  32. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015 Aug; 15(8):2188-96.
    View in: PubMed
    Score: 0.093
  33. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey. J Heart Lung Transplant. 2015 Jan; 34(1):65-74.
    View in: PubMed
    Score: 0.090
  34. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1564-7.
    View in: PubMed
    Score: 0.088
  35. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med. 2014 Mar 01; 189(5):567-75.
    View in: PubMed
    Score: 0.086
  36. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014 Feb; 14(2):446-52.
    View in: PubMed
    Score: 0.085
  37. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013 Aug; 144(2):616-622.
    View in: PubMed
    Score: 0.083
  38. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):527-34.
    View in: PubMed
    Score: 0.079
  39. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012; 7(12):e51932.
    View in: PubMed
    Score: 0.079
  40. Executive summary: monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):1284-1288.
    View in: PubMed
    Score: 0.078
  41. Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):e1S-e111S.
    View in: PubMed
    Score: 0.078
  42. SaLUTaRy: survey of lung transplant rejection. J Heart Lung Transplant. 2012 Sep; 31(9):972-9.
    View in: PubMed
    Score: 0.078
  43. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52.
    View in: PubMed
    Score: 0.077
  44. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012 Sep; 31(9):942-9.
    View in: PubMed
    Score: 0.076
  45. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011 Nov 01; 184(9):1055-61.
    View in: PubMed
    Score: 0.073
  46. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant. 2011 Nov; 11(11):2517-22.
    View in: PubMed
    Score: 0.072
  47. Conventional and novel approaches to immunosuppression. Clin Chest Med. 2011 Jun; 32(2):265-77.
    View in: PubMed
    Score: 0.071
  48. Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine. Respir Res. 2011 Apr 10; 12:44.
    View in: PubMed
    Score: 0.070
  49. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest. 2011 Aug; 140(2):489-496.
    View in: PubMed
    Score: 0.070
  50. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant. 2011 Mar; 11(3):561-7.
    View in: PubMed
    Score: 0.070
  51. Early readmission is a predictor of overall survival following isolated lung transplantation. Int Surg. 2010 Oct-Dec; 95(4):299-304.
    View in: PubMed
    Score: 0.068
  52. Clinical pathway after lung transplantation shortens hospital length of stay without affecting outcome. Int Surg. 2007 Mar-Apr; 92(2):93-8.
    View in: PubMed
    Score: 0.053
  53. Thoracic organ transplantation in the United States, 1995-2004. Am J Transplant. 2006; 6(5 Pt 2):1188-97.
    View in: PubMed
    Score: 0.049
  54. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation. 2001 Mar 27; 71(6):773-7.
    View in: PubMed
    Score: 0.035
  55. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant. 2000; 5(3):44-7.
    View in: PubMed
    Score: 0.032
  56. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med. 2015 Apr 22; 7(284):284re3.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.